Official Publication of Houston Methodist DeBakey Heart & Vascular Center
IN THIS ISSUE
Heart Failure in Relation to Anthracyclines and Other Chemotherapies
Heart Failure in Relation to Tumor-Targeted Therapies and Immunotherapies
The Role of Cardiovascular Imaging and Serum Biomarkers in Identifying Cardiotoxicity Related to Cancer Therapeutics
Prevention and Treatment of Chemotherapy-Induced Cardiotoxicity
Cardiovascular Toxicities of Radiation Therapy
Electrophysiologic Complications in Cancer Patients
Vascular Toxicity in Patients with Cancer: Is There a Recipe to Clarify Treatment?
Future Directions in Cardio-Oncology
A Rare Case of Pancreatitis-Induced Thrombosis of the Aorta and Superior Mesenteric Artery
Anomalous Origin of the Right Coronary Artery from the Left Main Coronary Artery in the Setting of Critical Bicuspid Aortic Valve Stenosis
Simultaneous Transfemoral Mitral and Tricuspid Valve in Ring Implantation: First Case Report with Edwards Sapien 3 Valve
Uneventful Follow-Up 2 Years after Endovascular Treatment of a High Flow Iatrogenic Aortocaval Fistula Causing Pulmonary Hypertension and Right Heart Failure
Do Not Pass Flow: Microvascular Obstruction on Cardiac Magnetic Resonance After Reinfarction Following Primary Percutaneous Coronary Intervention
Cardio-Oncology, Then and Now: An Interview with Barry Trachtenberg
Letter to the Editor in Response to “Cardiac Autonomic Neuropathy in Diabetes Mellitus”
Vol 15, Issue 4 (2019)
Showing results for keyword “ SGLT2 inhibitors”
Patricia Mejia Osuna Vol 14, Issue 4
Keywords: heart failure , type 2 diabetes , therapeutic options , DPP-4 inhibitors , GLP-1 agonists , SGLT2 inhibitorsOsuna PM, Brown SJ, Tabatabai LS, Hamilton DJ. Stage-Based Management of Type 2 Diabetes Mellitus with Heart Failure. Methodist DeBakey Cardiovasc J. 2018;14(4):257-65.
